U2Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2014
Period Ending	Mar '26 Mar 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '14 Dec 31, 2014
Market Capitalization	302,717	53,093	30,080	59,596	49,318	-
Market Cap Growth	869.96%	76.50%	-49.53%	20.84%	-	-
Enterprise Value	271,393	23,146	-3,866	23,197	52,691	-
Last Close Price	19000.00	3920.00	2596.84	5144.96	6286.26	-
PE Ratio	-	-	-	92.27	3.75	-
PS Ratio	11.83	2.08	1.20	1.94	0.72	-
PB Ratio	7.16	1.25	0.87	1.57	1.46	-
P/TBV Ratio	7.23	1.27	0.88	1.58	1.47	-
P/FCF Ratio	-	-	-	-	2.10	-
P/OCF Ratio	-	-	-	-	2.02	-
EV/Sales Ratio	10.60	0.90	-	0.75	0.76	-
EV/EBITDA Ratio	-	-	-	-	3.18	-
EV/EBIT Ratio	-	-	-	-	3.35	-
EV/FCF Ratio	-164.09	-	-	-	2.25	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	1.13
Debt / EBITDA Ratio	-	-	-	-	0.03	4.77
Debt / FCF Ratio	-	-	-	-	0.02	-
Net Debt / Equity Ratio	-0.74	-0.74	-0.97	-0.96	-1.08	0.87
Net Debt / EBITDA Ratio	23.08	23.08	16.35	86.70	-2.19	3.68
Net Debt / FCF Ratio	18.94	18.94	18.90	13.12	-1.55	-2.28
Asset Turnover	0.53	0.53	0.53	0.61	-	1.06
Inventory Turnover	27.56	27.56	26.49	30.54	-	18.23
Quick Ratio	6.24	6.24	6.27	5.52	3.22	1.79
Current Ratio	6.39	6.39	6.40	5.64	3.27	1.88
Return on Equity (ROE)	-4.28%	-4.28%	-7.85%	1.80%	-	9.93%
Return on Assets (ROA)	-2.81%	-2.81%	-3.89%	-1.67%	-	4.15%
Return on Invested Capital (ROIC)	-29.99%	-36.92%	-229.92%	-	547.93%	11.16%
Return on Capital Employed (ROCE)	-4.80%	-4.80%	-7.60%	-3.20%	43.20%	11.10%
Earnings Yield	-0.54%	-3.09%	-9.44%	1.08%	26.68%	-
FCF Yield	-0.55%	-3.12%	-5.90%	-4.65%	47.53%	-
Payout Ratio	-	-	-	195.50%	5.76%	-
Buyback Yield / Dilution	-3.32%	-3.32%	-9.26%	-2.14%	-598.90%	-22.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.